Skip to Content

Onco, Volume 1, Issue 1

2021 September - 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Article
  • Open Access
3 Citations
5,416 Views
11 Pages

Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma

  • Daniel Zeitouni,
  • Michael P. Catalino,
  • Jordan Wise,
  • Sean McCabe and ,
  • Kathryn Pietrosimone,
  • Naim Rashid and
  • Simon Khagi
  • + 2 authors+ 0 author

17 August 2021

BACKGROUND: Glioblastoma (GBM) is driven by various genomic alterations. Next-generation sequencing (NGS) could yield targetable alterations that might impact outcomes. The goal of this study was to describe how NGS can inform targeted therapy (TT) i...

  • Review
  • Open Access
5 Citations
6,782 Views
13 Pages

Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma

  • Brady Anderson,
  • Mary Vue,
  • Nya Gayluak,
  • Sarah Jane Brown and ,
  • Lynne T. Bemis and
  • Glenn E. Simmons
  • + 1 author+ 0 author

4 June 2021

Evidence of immunogenic cell death as a predictor of response to cancer therapy has increased interest in the high molecular group box 1 protein (HMGB1). HMGB1 is a nuclear protein associated with chromatin organization and DNA damage repair. HMGB1 i...

  • Systematic Review
  • Open Access
5 Citations
6,064 Views
20 Pages

The Impact of Immune Checkpoint-Inhibitors Therapy in Urinary Bladder Cancer

  • Ana Lúcia Silva,
  • Pedro Abreu-Mendes,
  • Diana Martins and
  • Fernando Mendes

4 March 2021

Bladder cancer (BC) is one of the most common cancers in the world. From an early age, it was observed that chronic inflammation is associated with conditions favorable to the development of tumors, as well as the tumor microenvironment. Moreover, re...

XFacebookLinkedIn
Onco - ISSN 2673-7523